NCT00436696View on ClinicalTrials.gov

Genetic Analysis Using Blood or Bone Marrow From Participants With Neuroblastoma or Noncancerous Conditions

CompletedOBSERVATIONAL

Enrollment

9,350

Participants

Timeline

Start Date

December 11, 2006

Primary Completion Date

May 5, 2016

Conditions

Localized Resectable NeuroblastomaLocalized Unresectable NeuroblastomaRecurrent NeuroblastomaRegional NeuroblastomaStage 4 Neuroblastoma

Interventions

OTHER

Laboratory Biomarker Analysis

Correlative studies

Trial Locations (2)

19104

Childrens Oncology Group, Philadelphia

39216

University of Mississippi Medical Center, Jackson

All Listed Sponsors

collaborator

National Cancer Institute (NCI)

NIH

lead

Children's Oncology Group

NETWORK

NCT00436696 - Genetic Analysis Using Blood or Bone Marrow From Participants With Neuroblastoma or Noncancerous Conditions | Biotech Hunter | Biotech Hunter